| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.36B | -0.6% |
| Cost of Revenue | $3.76B | -0.1% |
| Gross Profit | $1.60B | -1.7% |
| R&D Expense | $81.9M | -12.3% |
| SG&A Expense | $744.9M | -1.0% |
| Operating Income | $725.7M | -1.4% |
| Pre-tax Income | $476.5M | +3.9% |
| Income Tax | $35.3M | -81.3% |
| Net Income | $505.5M | +91.0% |
| EPS (Basic) | $3.44 | +89.0% |
| EPS (Diluted) | $3.43 | +89.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $344.0M | -7.5% |
| Accounts Receivable | $522.2M | +17.9% |
| Inventory | $737.0M | +2.0% |
| Current Assets | $1.92B | +1.5% |
| Total Assets | $7.01B | -0.1% |
| Current Liabilities | $2.10B | +28.5% |
| Long-term Debt | $3.94B | -8.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $628.0M | -13.7% |
| Capital Expenditures | $169.5M | -23.0% |
| Investing Cash Flow | -$133.6M | +42.5% |
| Financing Cash Flow | -$567.6M | -31.1% |
| Free Cash Flow | $458.5M | -9.7% |
| Total Liabilities |
| $5.78B |
| -9.7% |
| Stockholders' Equity | $1.24B | +98.2% |